Integrated screening reveals rare co-infections of gambiense human African trypanosomiasis, malaria and loiasis in Banga, northern Angola

Read full text
Authors: MBUENO NZILA, Fátima Nogueira, Maria Lina Antunes, Luis Baião Peliganga, Don Paul Makana, Tietie Claudia Elisa, Joaquim António Pedro, André Rodrigues, Helena Mariana Pitangueira Teixeira, Tatiana Maciel Gomes, Amadeu Dala, Constantina Pereira Furtado Machado
Cited by: 0
References: 13

Abstract

ABSTRACT Gambiense human African trypanosomiasis (gHAT), malaria, and loiasis overlap geographically in Central Africa and share non-specific clinical features. As gHAT incidence declines, integrated screening in co-endemic settings must balance sensitivity, specificity, and programmatic efficiency. We conducted a retrospective cross-sectional analysis of data from an integrated active community screening program conducted between June and September 2021 in Banga municipality, Cuanza Norte Province, Angola. Demographic and diagnostic data for malaria ( Plasmodium falciparum ), gHAT ( Trypanosoma brucei gambiense ), and loiasis ( Loa loa ) were analysed. Malaria was diagnosed using rapid diagnostic tests; gHAT was screened serologically with parasitological confirmation; loiasis was detected incidentally during parasitological examinations. Prevalence estimates were stratified by sex, age group, and commune. Associations were assessed using chi-square or Fisher’s exact tests, and multivariable logistic regression was used to evaluate factors associated with malaria infection. Among 6,117 screened individuals, malaria was highly prevalent (62.9%), with substantial heterogeneity by age and commune. Prevalence was highest in children aged 5–14 years (>70%) and decreased progressively with increasing age. Male sex was independently associated with malaria infection (adjusted OR 1.39; 95% CI 1.26–1.53), as was commune of residence (p

Fields of Study & Subjects

Trypanosoma species research and implications Malaria Research and Control Parasitic Diseases Research and Treatment

Publication details

Journal / source
medRxiv
Publication date
10 March 2026
Language
EN
Document type
Preprint